IL6 and COVID-19: In patients with COVID-19, the production of GM-CSF initiates a positive feedback loop, leading to the overexpression of interleukin-6 (IL-6) and other proinflammatory factors, particularly by CD14+ and CD16+ inflammatory monocytes (53).